MENNINI, NATASCIA
 Distribuzione geografica
Continente #
NA - Nord America 5.490
EU - Europa 3.803
AS - Asia 2.597
SA - Sud America 466
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 71
OC - Oceania 29
Totale 12.597
Nazione #
US - Stati Uniti d'America 5.386
IT - Italia 1.204
RU - Federazione Russa 1.060
SG - Singapore 692
PL - Polonia 607
CN - Cina 590
BR - Brasile 366
HK - Hong Kong 330
VN - Vietnam 250
IE - Irlanda 240
IN - India 199
KR - Corea 196
SE - Svezia 167
DE - Germania 102
JO - Giordania 97
FR - Francia 89
FI - Finlandia 81
GB - Regno Unito 68
CA - Canada 65
BD - Bangladesh 50
NL - Olanda 48
TR - Turchia 41
UA - Ucraina 40
AR - Argentina 36
ES - Italia 36
JP - Giappone 36
ID - Indonesia 35
AU - Australia 29
EC - Ecuador 19
BE - Belgio 17
PK - Pakistan 16
EG - Egitto 15
IQ - Iraq 15
MX - Messico 15
CO - Colombia 13
ZA - Sudafrica 10
NG - Nigeria 9
PT - Portogallo 9
CI - Costa d'Avorio 8
VE - Venezuela 8
MA - Marocco 7
PY - Paraguay 7
TW - Taiwan 7
CL - Cile 6
PE - Perù 6
TN - Tunisia 6
CH - Svizzera 5
KE - Kenya 5
LT - Lituania 5
NP - Nepal 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
SA - Arabia Saudita 4
BJ - Benin 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DM - Dominica 3
GT - Guatemala 3
PH - Filippine 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SM - San Marino 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AT - Austria 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
QA - Qatar 1
Totale 12.455
Città #
Santa Clara 1.177
Warsaw 603
Ashburn 578
Singapore 498
Fairfield 397
Hong Kong 272
Dublin 240
San Jose 229
Woodbridge 223
Chandler 218
Florence 190
Seoul 190
Houston 181
Seattle 178
Beijing 151
Cambridge 148
Wilmington 142
Milan 128
Ann Arbor 127
Hefei 122
The Dalles 109
Council Bluffs 106
Rome 92
Ho Chi Minh City 85
Altamura 77
Los Angeles 76
Lawrence 72
Princeton 68
Dallas 61
Jacksonville 60
Lauterbourg 59
Hanoi 55
Buffalo 48
Boardman 42
New York 41
Boston 38
Moscow 38
São Paulo 34
Medford 33
Tokyo 33
Izmir 30
Mumbai 30
Melbourne 29
Munich 28
San Diego 26
Paris 25
Chicago 24
Helsinki 24
Shanghai 24
Naples 23
Bengaluru 22
Kent 22
Orem 22
Hyderabad 21
Jakarta 19
Turin 19
Pescara 18
Clifton 17
Trieste 16
Brussels 15
Toronto 15
Chennai 14
Da Nang 13
Barcelona 12
Figino 11
Modugno 11
Giza 10
Guangzhou 10
Madrid 10
Mexico City 10
Rio de Janeiro 10
Baghdad 9
Brooklyn 9
Catania 9
Manchester 9
Norwalk 9
Pune 9
Salt Lake City 9
Abidjan 8
Abuja 8
Ahmedabad 8
Bologna 8
Cagliari 8
Frankfurt am Main 8
Genoa 8
Hangzhou 8
London 8
Lucknow 8
Montreal 8
North Bergen 8
Ottawa 8
Poplar 8
Amman 7
Amsterdam 7
Atlanta 7
Brescia 7
Den Haag 7
Haiphong 7
Johannesburg 7
Lappeenranta 7
Totale 8.030
Nome #
Advanced moist wound dressing: classification by function 521
Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state 416
Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins 382
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 336
Sistemi Micro e Nanoparticellari per l’Ottimizzazionedei Farmaci 309
Development of a new delivery system consisting in "drug-in cyclodextrin- in nanostructured lipid carriers" for ketoprofen topical delivery 289
Amidated pectin-based wafers for econazole buccal delivery: Formulation optimization and antimicrobial efficacy estimation 250
Solid lipid nanoparticles as new strategy for oral delivery of nebivolol hydrochloride 243
Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen 234
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 231
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 228
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 221
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 209
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 209
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 208
Characterization and evaluation of the performance of different calcium and magnesium salts as excipients for direct compression 206
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 196
In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. 195
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 194
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 192
Development and characterization of naproxen-chitosan solid systems with improved dissolution properties 191
Development and characterization of functionalized niosomes for brain targeting of dynorphin-B 187
New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs 186
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 184
Quality by design in the optimization of a nanosystem-ethosomal formulation for topical treatment of vitiligo 184
Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting 183
Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates 178
In silico modeling of retention times in Supercritical Fluid Chromatography (SFC) coupled with UV detector using QSRR approach 177
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations 175
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 174
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 174
Development and optimization by Quality by Design strategies of frovatriptan orally disintegrating tablets for migraine management 172
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 171
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 170
Dalla laurea alla professione oggi, passando per i servizi universitari di placement 170
Quality by Design and capillary electrophoresis in the development of thymoquinone-loaded vesicular systems for topical treatment of vitiligo 165
Combined use of cyclodextrins and amino acids for the development of cefixime oral solutions for pediatric use 164
Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: Effect of cyclodextrin complexation 163
Development of mucoadhesive films for buccal administration of flufenamic acid: Effect of cyclodextrin complexation. 160
Technical Evaluation of a New Medical Device Based on Rigenase in the Treatment of Chronic Skin Lesions 159
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 154
Improvement of butamben anesthetic efficacy by the development of deformable liposomes bearing the drug as cyclodextrin complex 154
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery 153
Mixture experiment methods in the development and optimization of microemulsion formulations 148
Development of a chitosan-derivative micellar formulation to improve celecoxib asolubility and bioavailability 148
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review 147
Researching the level of agreement among experts on terms used to describe wounds: An international study 146
Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management 146
Sustained release matrix tablets of metformin hydrochloride in combination with triacetyl-ß-cyclodextrin 145
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 144
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery 143
EFFECT OF CHITOSAN ON DISSOLUTION PROPERTIES OF NAPROXEN 142
Development of orally disintegrating tablets (ODTs) of frovatriptan by use of Quality by Design strategies 142
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids 139
Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anaesthetic efficacy 128
Mixture design and capillary electrophoresis as analytical tools for the optimization of functionalized niosomes 127
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-ß-cyclodextrin complex 126
Development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 126
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers 125
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components 125
Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems 122
Experimental design methodologies in the development of mucoadhesive wafers loaded with econazole 115
Curcumin’s niosomes coated with chitosan for the treatment of osteoarthritis: effect of cyclodextrin complexation 104
Experimental design and capillary electrophoresis in the development of cyclodextrin-based hydrogels for oral administration of oxaprozin 104
Quality of wound dressings: A first step in establishing shared criteria and objective procedures to evaluate their performance 104
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 103
Quality by Design and capillary electrophoresis for developing orally disintegrating tablets containing frovatriptan 100
Quality by Design approach for developing Chitosan-Ca-alginate microspheres for colon delivery of Celecoxib-hydroxypropyl-beta-cyclodextrin-PVP complex. 93
Mucoadhesive wafers loaded with econazole-cyclodextrin complexes for treatment of oral candidiasis 82
Natural active-based NLC hydrogels combining pomegranate oil and Sedum telephium polysaccharides for pediatric burn management 43
Natural active-based NLC hydrogels combining pomegranate oil and Sedum telephium polysaccharides for pediatric burn management 27
Metodo e apparato per la misurazione della conformabilità di una medicazione al letto di lesione 24
Development and characterization of orally disintegrating films of Nebivolol as complex with Sulfobutylether-β-cyclodextrin 12
Totale 12.597
Categoria #
all - tutte 33.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022408 0 37 50 16 10 16 20 24 18 18 77 122
2022/20231.089 97 195 44 83 81 161 155 47 169 12 28 17
2023/2024416 27 44 61 14 26 32 12 95 24 27 26 28
2024/20253.388 99 324 226 469 1.057 378 103 164 164 90 191 123
2025/20264.275 310 628 374 387 506 216 421 239 406 218 156 414
2026/2027299 190 109 0 0 0 0 0 0 0 0 0 0
Totale 12.597